Diamonds and Dogs
La La Land and La Jolla Pharma (LJPC) are big winners today. La Jolla Pharma is up 83% following positive phase 3 study results. La Jolla's drug showed positive treatment for catecholamine-resistant hypotension, or CRH which is a life-threatening condition in which blood does not properly flow to vital organs. The analyst at SunTrust upgraded the stock with a $57 target from $38. Not bad.
TSLA is down 4% today on a downgrade from Goldman Sachs. Tesla is now down 13% in the last four trading days following earnings and a wider than expected loss per share, but the automaker did announce that the mass-market electric Model 3 sedan is on track for initial production in July. Goldman lowered their price target on Tesla to $185 from $190 so it sounds like they were a bear on the stock for a while.